Kevin Lamote

Department of Internal medicine

work address

C. Heymanslaan 10, 7K12-IE
9000 Gent

email

Kevin.Lamote@UGent.be

1 – 25 of 25

show: 250
|
sort: year (new to old)

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/person/000060516983?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

2017
- A1
- journalArticle
Biomarkers for early diagnosis of malignant mesothelioma : do we need another moonshot?
Sabrina Lagniau, Kevin Lamote UGent, Jan Van Meerbeeck UGent and Karim Vermaelen UGent (2017) ONCOTARGET. 8(32). p.53751-53762 Mark
- A1
- journalArticle
Exhaled breath to screen for malignant pleural mesothelioma : a validation study
Kevin Lamote UGent, Matthijs Vynck UGent, Olivier Thas UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2017) EUROPEAN RESPIRATORY JOURNAL. 50(6). Mark
- dissertation
Volatile organic compounds and malignant pleural mesothelioma : simply breathtaking?
Kevin Lamote UGent (2017) Mark
- C3
- conference
Breath analysis by gas chromatography-mass spectrometry can be used to screen for pleural mesothelioma
Kevin Lamote UGent, Lore Vandermeersch UGent, Herman Van Langenhove UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2017) In JOURNAL OF THORACIC ONCOLOGY 12(1, suppl.). p.S331-S331 Mark
- C3
- conference
Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma
Kevin Lamote UGent, Matthijs Vynck UGent, Olivier Thas UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2017) EUROPEAN RESPIRATORY JOURNAL. 50(suppl. 61). Mark
- A1
- journalArticle
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma : a cross-sectional case-control study
Kevin Lamote UGent, Paul Brinkman, Lore Vandermeersch UGent, Matthijs Vynck UGent, Peter J Sterk, Herman Van Langenhove UGent, Olivier Thas UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2017) ONCOTARGET. 8(53). p.91593-91602 Mark
2016
- A1
- journalArticle
Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS)
Kevin Lamote UGent, Matthijs Vynck UGent, Joris Van Cleemput, Olivier Thas UGent, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2016) JOURNAL OF BREATH RESEARCH. 10(4). Mark
- C3
- conference
Breath analysis by gas chromatography-mass spectrometry can be used to screen for pleural mesothelioma
Kevin Lamote UGent, Joris Van Cleemput, Kristiaan Nackaerts, Lore Vandermeersch UGent, Herman Van Langenhove UGent and Jan Van Meerbeeck UGent (2016) EUROPEAN RESPIRATORY JOURNAL. 48(60). Mark
- C3
- conference
VOC analysis in headspace air of mesothelioma and lung cancer cell lines: a comparative literature study
Sabrina Lagniau, Kevin Lamote UGent, Karim Vermaelen UGent and Jan Van Meerbeeck UGent (2016) EUROPEAN RESPIRATORY JOURNAL. 48(60). Mark
2015
- C3
- conference
Exhaled breath as diagnostic tool for malignant pleural mesothelioma
Kevin Lamote UGent, Filip Lardon, Joris Van Cleemput, Kristiaan Nackaerts, Olivier Thas UGent and Jan Van Meerbeeck UGent (2015) CANCER RESEARCH. 75(15, suppl.). Mark
- C3
- conference
Breath analysis by ion mobility spectrometry allows discrimination of pleural mesothelioma patients from controls
Kevin Lamote UGent, Matthijs Vynck UGent, Joris Van Cleemput, Olivier Thas UGent, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2015) JOURNAL OF THORACIC ONCOLOGY. 10(suppl. 2). p.S350-S350 Mark
- misc
Breathomics: analyse respiratoire non invasive pour le diagnostic du cancer pulmonaire
Kevin Lamote UGent and Jan Van Meerbeeck UGent (2015) ONCO HEMATO. 9(6). p.19-28 Mark
- C3
- conference
Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma
Kevin Lamote UGent, Matthijs Vynck UGent, Joris Van Cleemput, Olivier Thas UGent, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2015) EUROPEAN RESPIRATORY JOURNAL. 46(suppl. 59). Mark
- A2
- journalArticle
Breathomics: niet-invasieve ademanalyse voor longkanker diagnose
Kevin Lamote UGent and Jan Van Meerbeeck UGent (2015) ONCO-HEMATO. 9(6). p.19-28 Mark
2014
- A1
- journalArticle
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma: a hypothesis
Kevin Lamote UGent, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2014) CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 23(6). p.898-908 Mark
- C3
- conference
A breath test for diagnosing malignant pleural mesothelioma
Kevin Lamote UGent, Birgitta Hiddinga, Joris Van Cleemput, Kristiaan Nackaerts, Olivier Thas UGent and Jan Van Meerbeeck UGent (2014) ANNALS OF ONCOLOGY. 25(suppl. 4). p.iv543-iv543 Mark
- C3
- conference
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
Kevin Lamote UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2014) EUROPEAN RESPIRATORY JOURNAL. 44(suppl. 58). Mark
2013
- A1
- journalArticle
Fibulin-3 as a biomarker for pleural mesothelioma
Kevin Lamote UGent, Paul Baas and Jan Van Meerbeeck UGent (2013) NEW ENGLAND JOURNAL OF MEDICINE. 368(2). p.189-190 Mark
- C3
- conference
Screening tools for a high risk population: can we screen for early mesothelioma?
Jan Van Meerbeeck UGent and Kevin Lamote UGent (2013) JOURNAL OF THORACIC ONCOLOGY. 8(suppl. 2). p.S107-S108 Mark
- C3
- conference
Volatile organic compounds as a diagnostic tool for malignant pleural mesothelioma
Kevin Lamote UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2013) Markers in Cancer, ASCO-EORTC-NIC Annual meeting, Abstracts. Mark
- C3
- conference
Volatile organic compounds as diagnostic tool for malignant pleural mesothelioma
Kevin Lamote UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2013) JOURNAL OF THORACIC ONCOLOGY. 8(suppl. 2). p.S1234-S1234 Mark
- C3
- conference
Volatile organic compounds in the breath of cystic fibrosis patients: a pilot phase
Kevin Lamote UGent, Guy Joos UGent and Jan Van Meerbeeck UGent (2013) Breath Analysis Summit, Abstracts. Mark
- C3
- conference
Volatile organic compounds as a diagnostic tool for malignant pleural mesothelioma
Kevin Lamote UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2013) Lung Cancer, 15th World conference, Abstracts. Mark
- C3
- conference
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
Kevin Lamote UGent, Joris Van Cleemput, Kristiaan Nackaerts and Jan Van Meerbeeck UGent (2013) EUROPEAN JOURNAL OF CANCER. 49(suppl. 4). p.S25-S25 Mark
2012
- A1
- journalArticle
Calcium phosphate cements modified with pore expanded SBA-15 materials
Natasja Van den Vreken UGent, Els De Canck UGent, Matthias Ide, Kevin Lamote UGent, Pascal Van Der Voort UGent and Ronald Verbeeck (2012) JOURNAL OF MATERIALS CHEMISTRY. 22(29). p.14502-14509 Mark